HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accelerated hypertriglyceridemia in patients on continuous ambulatory peritoneal dialysis - a preventable abnormality.

Abstract
Increasing hypertriglyceridemia is a recognised complication of CAPD. To investigate the etiology lipid clearance studies using the intravenous fat tolerance test were performed in control subjects and in uremic patients before and after six months CAPD treatment. Oral carbohydrate intake was restricted and the use of hypertonic dialysate kept to a minimum. Although serum triglycerides were elevated in the uremic patients before CAPD (3.1 +/- 0.3 mMol/L) no further increase occurred during therapy. Oral carbohydrate intake was restricted to 240-250 Gms/24 hrs and hypertonic dialysate to 5.7 +/- 4.1% of the total. There were no significant changes in fractional removal rate of lipid. Therefore further increases in serum triglycerides in CAPD may be prevented by simple dietary manoeuvres.
AuthorsC Turgan, J Feehally, S Bennett, T J Davies, J Walls
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 4 Issue 4 Pg. 158-60 (Jul 1981) ISSN: 0391-3988 [Print] United States
PMID7035376 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Dietary Carbohydrates
  • Insulin
  • Urea
  • Creatinine
Topics
  • Adult
  • Blood Glucose (metabolism)
  • Creatinine (blood)
  • Dietary Carbohydrates (therapeutic use)
  • Female
  • Humans
  • Hyperlipoproteinemias (blood, prevention & control)
  • Insulin (blood)
  • Kidney Failure, Chronic (therapy)
  • Male
  • Middle Aged
  • Peritoneal Dialysis (adverse effects)
  • Peritoneal Dialysis, Continuous Ambulatory (adverse effects)
  • Urea (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: